Earnings calls

Ajanta Pharma concall ledger

Every earnings call for AJANTPHARM — management tone, guidance, KPIs and promise tracking, quarter by quarter.

AJANTPHARM · 2 transcripts · Healthcare · latest Q4 FY26

Q4 FY26Published 05 May 2026Call held 05 May 2026

AJANTPHARM Q4 FY26 Earnings Call Transcript & Analysis

Revenue from Operations₹5,453 cr+17% YoYEBITDA₹1,395 cr+11% YoYEBITDA Margin26%Net Profit₹1,056 cr+15% YoYGross Margin78%

Revenue from Operations (FY26) ₹5,453 cr (+17% YoY); EBITDA (FY26) ₹1,395 cr (+11% YoY); EBITDA Margin (FY26) 26%. FY26 Revenue surpassed ₹5,000 crores, Net Profit crossed ₹1,000 crores.

Read full transcript & analysis

Q2 FY26Published 30 Jan 2026Call held 30 Jan 2026

AJANTPHARM Q2 FY26 Earnings Call Transcript & Analysis

Revenue₹1,375 cr+20% YoYEBITDA₹382 cr+19% YoYEBITDA Margin28%PAT₹274 cr+18% YoYGross Margin79%

Revenue ₹1,375 cr (+20% YoY); EBITDA ₹382 cr (+19% YoY); EBITDA Margin 28%. Total Revenue for Q3 stood at ₹1,375 crores, registering a healthy growth of 20% YoY.

Read full transcript & analysis